CECIP Jau - Centro de Estudos Clínicos do Interior Paulista Ltda

CECIP Jau - Centro de Estudos Clínicos do Interior Paulista Ltda
R. Bento Manoel, 290 - Centro, Jaú - SP, 17201-130
Select an option

Our team

Medical staff
Daniela Zanatto
Marcia Pavaneli
Lenize Trindade Felipe
Edilaine Sábio
Julia Dangio
Abner Gomes
Bruna Meyer de Mattos Correa

Open studies

Crohn's disease
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease - TakedaSee more
A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease - SIBERITE-PEDS - Hoffmann-La RocheSee more
Cardiovascular disease
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) - ATTAIN-Outcomes - Eli Lilly and CompanySee more
Renal disease
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) - ATTAIN-Outcomes - Eli Lilly and CompanySee more
Aphthous Stomatitis
Efficacy and Safety of BNP105 in the Treatment of Recurrent Aphthous Stomatitis - EMSSee more
Chronic obstructive pulmonary disease
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006) - EMBARK - AstraZenecaSee more
Ulcerative colitis
A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis - AMETRINE-PEDS - Hoffmann-La RocheSee more
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy